Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness

Archives of Neurology

Volumn 60, Issue 2, 2003, Pages 260-264

  Mygland, Ase ^a,b   Monstad, Per ^a  

^a Vest Agder Central Hospital   (Norway)

^b Spesialsykehuset for Rehabilitering HF   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; M PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; DEMYELINATING DISEASE; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTRODIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NORWAY; POLYNEUROPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MUSCLE WEAKNESS; POLYNEUROPATHIES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 0037320313     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.2.260     Document Type: Article

References (14)

1. Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1993:1498-1517.
2. Ropper A, Gorson K. Neuropathies associated with paraproteinemia. N Engl J Med. 1998;338:1601-1606.
3. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54:615-620.
4. Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol. 2001;8:157-165.
5. van Swieten JC, Koudstaal MD, Visser MC, Schouten HJ, van Gijn J. Interobserver agreementfor the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
6. Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989;12:435-451.
7. Lunn MPT, Manji H, Choudhary PP, Hughes RAC, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry. 1999;66:677-680.
8. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Neurology. 1999;46:910-913.
9. Oh SJ, Joy JL, Kuruoglu R. "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry. 1992;55:677-680.
10. Levine TD, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology. 1999;52:1701-1704.
11. Notermans NC, Lokhorst HM, Franssen H, et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology. 1996;47:1227-1233.
12. Latov N, Hays AP, Sherman WH. Peripheral neuropathy and anti-MAG antibodies. Crit Rev Neurobiol. 1988;3:301-332.
13. Gorson K, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48:321-328.
14. Simmons Z, Alber JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology. 1993;43:2202-2209.